Jobs
View more job listings or post a job
How Cancer LLC Social Media Digital Marketing Specialist  
How Cancer LLC Syndicated National Writer - Cancer 
University of California, Davis SCREENING SUPERVISOR
InnoAlliance Scientist/Sr Scientist of Bioanalysis & Biomarkers
Bioduro-Sundia Associate Director/Director in Laboratory Animal and Exploratory Toxicology
Variant Bio (Senior) Scientist - DMPK
Alturas Analytics Scientist 1
University of California, Davis TOXICOLOGY ANALYTICAL CHEMIST (STAFF RESEARCH ASSOCIATE 3)
Post a job

Workshop

[Free Online Workshop] Unleashing the Power of Real-World Evidence / Data (RWE/RWD) to Facilitate Drug Discovery, Development, and Beyond


Speakers: Lixia Yao, Polygon Health Analytics LLC; Aaron Mackey, Lokavant; Ying Li, Regeneron Pharmaceuticals, Inc.; Daisuke Goto, Organon & Co.; Star Chen, Merck & Co.
Organizers: Lixia Yao - Founder & CEO, Polygon Health Analytics LLC
Date: 2024-10-25
Time: 8:30-12:00 Pacific Time
Registration fee: Free
Location: Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2024-10-24  (it will close sooner if the seating cap is reached)

About the Topic

Real-world data (RWD) are data relating to patient health status and/or the delivery of health care routinely collected from a variety of sources, and Real-world evidence (RWE) is the clinical evidence about the usage and potential benefits or risks of a medical product derived from analysis of RWD. In this workshop, we delve into the transformative power of RWD and RWE in the pharmaceutical industry, which may transform every facet of the pharma industry from discovery to marketing. 

The following topics will be covered:

  • Definitions, sources, and implications of RWD and RWE in today’s healthcare landscape. 
  • RWD and RWE for drug discovery, highlighting how RWD can identify new therapeutic targets and accelerate new drug discovery
  • The role of RWD in clinical development, including designing innovative trials, enhancing patient recruitment, and improving outcomes
  • Health Economics and Outcome Research (HEOR), demonstrating the potential of RWD/RWE in cost-effectiveness analysis, budget impact analysis, and health technology assessment
  • Strategic utilization of RWD in pharma marketing, discussing how it can inform strategies, support product positioning, and provide insights into market dynamics
  • FDA's approaches on RWD and RWE for drug approval and regulation
Time (PST) Topic Presenter(s)
8:30 – 8:45 am PBSS Welcome and Introduction Shichang Miao, PhD, PBSS
8:45 – 9:25 am Introduction to Real-world Data and Real-world Evidence Lixia Yao, PhD, Founder & CEO, Polygon Health Analytics LLC
9:25 – 10:05 am Real-world Data for Drug Discovery Aaron Mackey, PhD, SVP, AI & Data Science, Lokavant
10:05 – 10:45 am Real-world Data for Clinical Development Ying Li, PhD, Director, RWE and advanced analytics, Regeneron Pharmaceuticals, Inc.
10:45 – 11:25 am Real-world Data for Health Economics and Outcome Research (HEOR)  Daisuke Goto, PhD, Director, Medical Affairs and Outcomes Research, Organon & Co.
11:25 am – 12:00 pm  Panel Discussion Lixia Yao, Polygon Health Analytics LLC; Aaron Mackey, Lokavant; Ying Li, Regeneron Pharmaceuticals, Inc.; Daisuke Goto, Organon & Co.; Star Chen, Merck & Co.

 


2024-11-13, [Free Online Workshop] Career Transition for Research Scientists: Business Development & BioPartnering
2024-11-15, [In-Person] Current State of Bioanalysis for Biologics and Cell/Gene Therapy Products: Refining Established Approaches for New Complex Therapies
2024-12-05, [Free Online] Innovative Mass Spectrometry and Related Technologies for Life Science and Drug Development
2024-12-13, Why All These New Modalities?
2025-01-22, [In-Person] Small-Molecule Formulation for Discovery & Early Development (jointly by PBSS / AAPS-BADG / Syner-G)
2025-02-06, [In-Person] Intellectual Property (IP) Strategies and Best Practices
2025-02-26, [In-Person] Demystifying Biopharma Business Development
2025-03-07, [In-Person] Clinical Trial Planning and Conduct: Fundamentals, Strategies and Best Practices
2025-03-27, [Free Online Workshop] Biotech Financing 101: from Angels, Government Agencies, Foundations and VCs
©Pharmaceutical & BioScience Society, International; Last Modified: 11/5/2024; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Aliri Bioanalysis to the rescue! Pioneers in LCMS & Oligo bioanalysis w/ 30+ years of experience putting dev. programs back on track with quality data & fast timelines.
Aroga Biosciences Aroga Biosciences is an award-winning CRO specializing in scientific writing for nonclinical reports, INDs, CMC, and clinical documents.
Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Hypha Discovery Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
Allucent Bringing innovation to Biotech w/ClinPharm Modeling & Simulation services to inform dose, design, modeling + development strategies.
PharmaResources Top-tier small molecule CRO/CDMO offering comprehensive supports from Medicinal Chemistry, DMPK, and CMC to GMP manufacturing for commercialization.
Submit a Text Ad